French to modify breast implant ban soon?
This article was originally published in Clinica
Executive Summary
A decree relaxing the French ban on the sale and implantation of all non-saline breast prostheses could be published before the current ruling expires in May. Under present legislation, these products may only be sold once they have French premarket approval (homologation) through a type-testing procedure involving risk assessment. A spokesman for the Health Ministry explained to Clinica that the Ministries involved in drawing up the decree - Health and Economic Affairs - have come to an agreement that a new text should be published which would accept CE-marked breast implants on certain conditions.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.